Pfizer Inc and GSK are close to bringing the first two vaccines for RSV to the United States after gaining the backing of a panel of advisers to the FDA.
ICU Medical has teamed up with a private equity firm to challenge GE Healthcare Technologies in its pursuit of two medical technology businesses that Medtronic Plc is seeking to sell for between $8 billion and $9 billion, according to people familiar with the process.
Intra-Cellular Therapies’ Caplyta (lumateperone) met its primary endpoint in its Phase III trial, easing the burden of depressive episodes in patients with major depressive disorder (MDD) or bipolar depression with mixed features.
The company is discontinuing the late-stage study of its experimental respiratory syncytial virus adult vaccine, weeks after rivals Pfizer and GSK gained a lead in the race for the first vaccine against the virus.
ReutersThe approval for OTC use of the naloxone-based nasal spray will help align the federal government’s stance with states that have provisions to offer the drug without prescription at pharmacies.
ReutersThe request to consider obesity drugs was submitted by three doctors and a researcher in the United States and covers the active ingredient liraglutide in Novo Nordisk’s obesity drug Saxenda, which will come off patent soon, allowing for cheaper generic versions.